July 14,2006
Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs
Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.
Next Article Previous Article
Recent News
- Crapo Announces Executive Session to Consider Treasury, HHS Nominations
- The One Big Beautiful Bill Prioritizes America-First Energy
- The One Big Beautiful Bill Boosts Made-in-America Manufacturing
- Crapo Announces USTR, HHS, Treasury Nominations Hearing
- The One Big Beautiful Bill Drives Business Growth